Nuzenio

Unresponsive Bladder Cancer

Unresponsive Bladder Cancer news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Changing Chemotherapy Delivery in BCG-Unresponsive Bladder Cancer - CancerNetworkCancerNetwork · Fri, 07 Aug 2026 18:09:52 GMTBOND-003 Phase 3: Cretostimogene Shows 75% Complete Response Rate in BCG-Unresponsive NMIBC - OncodailyOncodaily · Sat, 01 Aug 2026 09:50:17 GMTDurable Responses Seen With Cretostimogene in BCG-Unresponsive NMIBC - Targeted OncologyTargeted Oncology · Wed, 29 Jul 2026 19:05:19 GMTImmunityBio Receives United Arab Emirates (UAE) Marketing Authorization for ANKTIVA® Across BCG-Unresponsive Non-Muscle Invasive Bladder Cancer for CIS and Papillary Disease and Metastatic Non-Small Cell Lung Cancer - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMTCretostimogene Grenadenorepvec Elicits Durable Complete Responses and Bladder Preservation in BCG-Unresponsive NMIBC - onclive.comonclive.com · Tue, 28 Jul 2026 07:00:00 GMT

Timeline

Fri, 07 Aug 2026 18:09:52 GMTChanging Chemotherapy Delivery in BCG-Unresponsive Bladder Cancer - CancerNetwork
Sat, 01 Aug 2026 09:50:17 GMTBOND-003 Phase 3: Cretostimogene Shows 75% Complete Response Rate in BCG-Unresponsive NMIBC - Oncodaily
Wed, 29 Jul 2026 19:05:19 GMTDurable Responses Seen With Cretostimogene in BCG-Unresponsive NMIBC - Targeted Oncology
Wed, 29 Jul 2026 07:00:00 GMTImmunityBio Receives United Arab Emirates (UAE) Marketing Authorization for ANKTIVA® Across BCG-Unresponsive Non-Muscle Invasive Bladder Cancer for CIS and Papillary Disease and Metastatic Non-Small Cell Lung Cancer - Yahoo Finance
Tue, 28 Jul 2026 07:00:00 GMTCretostimogene Grenadenorepvec Elicits Durable Complete Responses and Bladder Preservation in BCG-Unresponsive NMIBC - onclive.com

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Unresponsive Bladder Cancer.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.